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1. Introduction 
Thyrotropin-releasing factor (TRF) is a peptide 
which causes the release of thyroid-stimulating hor- 
mone (TSH) from the pituitary in mammals [l] . The 
sequence of this hormone has recently been deter- 
mined [ 1,2] to be L-pyroglutamyl-l-histidyl- 
L-prolinamide. 
Carbon-13 nuclear magnetic resonance (13C NMR) 
has proven useful in detecting cis and trans isomers of 
proline in peptides [3-61. The purpose of this study 
was to investigate cis-trans isomerism about the 
histidyl-prolinamide bond in TRF and to measure the 
spin-lattice relaxation times, Tr , of all the carbons in 
the hormone. TRF in water is found to have 14% of 
the proline present as the cis isomer - the amount 
varies with the solvent. The proline resonances are sen- 
sitive to the nature of the group attached to the proline 
nitrogen. 13C NMR is shown to be sensitive to the 
presence of D and L forms of histidine. The presence 
of D or L histidine in TRF has a profound influence 
on the 13C chemical shifts of proline, whereas those of 
pyroglutamate are unaffected. 
2. Material and methods 
NMR spectra of 13C in natural abundance were ob- 
tained at 25.16 MHz on a Varian XL-100-15 spectro- 
meter in the pulsed Fourier transform mode at 37” 
with complete proton noise decoupling. Spin-lattice 
relaxation times were measured using the inversion- 
recovery method of Freeman and Hill [7]. 
Thyrotropin-releasing factor (L-pyroglutamyl- 
L-histidyl-L-prolinamide, TRF) and the following 
model peptides were a gift from Dr. R.O. Studer 
(Hoffman, LaRoche, B$le): L-pyroglutamyl- 
N-methylamide, < Glu-NHMe; L-pyroglutamyl- 
L-histidyl-methyl ester, < Glu-His-OMe; L-pyro- 
glutamyl-L-histidyl-N,N-dimethyl amide, < Glu- 
His-NMe, ; acetyl prolinamide, AC-Pro-NH,. Other 
samples of TRF were a gift from Wyeth Laboratories 
or purchased from Bachem Fine Chemicals. TRF-R 
was synthetized at the Centre de Recherche Paul 
Pascal by E. Dupart and M. Joussot-Dubien. 
3. Results and discussion 
3.1. Cis- trans isomerism 
The chemical shifts of the compounds studied are 
given in table 1. Table 2 shows the percentage of cis 
isomer of proline about the His-Pro peptide bond in 
TRF and AC-Pro-NH,’ in different solvents. Measure- 
ment of cis content was made from peak intensities, 
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Fig.1. Carbon-13 NMR spectrum of TRF in DaO, 80 mg/ml, 1 ml in 12 mm outside diameter sample tube, pD 8.9, 7,379 tran- 
sients, pulse width 30”, cycle time 0.8 set, 8192 data points. 
Table 2 
Percentage of cis isomer about the histidyl-prolinamide bond 
in TRF and AC-Pro-NH? in different solvents. 
Solvent TRF Ac-Pro-NH2 
% cis % cis 
Dz0 14 25 
DMSO-ds 6 34 
Pyridine-ds 0 31 
cis Content in TRF was measured at pH 4.7, 5.5, 6.3, 8.9 and 
found not to vary more than 3% within this range. 
assuming that cis and truns isomers had the same re- 
laxation times and nuclear Overhauser enhancements 
[B] . The percentage of each isomer [3,4,6] could be 
measured on the 6, p or y carbons of proline in each 
spectrum. Results agreed within 1% in each spectrum. 
TRF in pyridine-ds shows no cis isomer, but’in the 
same solvent Ac-Pro-NH2 exists as 3 1% cis isomer. The 
largest amount of cis isomer (15%) in TRF is found in 
deuterium oxide, Dz 0 (fig.l), whereas the least 
amount of cis isomer of AC-Pro-NH, (25%) occurs in 
this solvent. The assumptions above can lead to errors 
in estimating the absolute amounts of the two isomers 
but the relative ratios of cis content in TRF and Ac- 
Pro-NH2 are significant. All measurements were done 
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on the same sample of TRF and Ac-Pro-NH* in the 
order given in table 2. As a further check, the samples 
were rerun in Dz 0 and identical results were obtained. 
Thus, we conclude the relative amounts of each iso- 
mer are solvent-dependent and that the solvent effects 
are different in the hormone and in the model peptide 
AC-Pro-NH,. It was not possible to measure accurate- 
ly the spin-lattice relaxation times of the carbons in 
the cis isomers due to their weak intensities. 
3.2. Chemical shift assignment 
In order to identify all the resonances in TRF, and 
to look for possible conformational peculiarities in 
TRF, model peptides were studied. The major differ- 
ences in the pyroglutamyl resonances of < Glu-His- 
OMe when compared with those of < Glu-NHMe are 
in the cv carbon and carbonyl carbon of the peptide 
link; the other carbon resonances of the pyroglutamic 
acid residue are identical. The spectra of < Glu-His- 
OMe and < Glu-His-NMe, are quite similar. The CY 
carbon of histidine and the carbonyl carbon of 
histidine and pyroglutamate are the only resonances 
which differ significantly. These differences are attri- 
buted to substituent effects [8,9]. In the case of the 
Volume 31, number 1 FEBS LE’lTERS April 1973 
(Y carbon of histidine, replacing an O-methyl group 
by an N, N-dimethylamide group in the y position pro- 
duces an upfield shift of 3 parts per million (ppm); 
the upfield shift of the carbonyl carbon can also be 
explained on the same basis. 
Changing the pH from 8.8 to 4.7 in <cGlu-His- 
NMe, produced no effect on the 13C resonances of 
the pyroglutamyl residue. The changes observed in the 
histidine residue are caused by protonation of the 
imidazole ring [lo] . 
The presence of a proline residue in TRF causes the 
(Y carbon of histidine to shift downfield 1.7 ppm with 
respect to its position in < Glu-His-NMe, . This dem- 
onstrates the importance of the y steric effect of 
prolme [ 11,121. When Ac-Pro-NH2 is compared to 
TRF, small differences are seen in the proline ring 
carbon resonances. This is not unexpected. However, 
carbons in the cis and trans isomers are not affected 
to the same extent. This could mean that the cis and 
trans proline rings have slightly different conforma- 
tions [ 121 or conformational equilibria [ 131 due to 
different interactions of the two isomers with the 
histidine residue. 
3.3. Racemized histidine in TRF 
Fig.2 shows that one sample of TRF (TRF-R) 
gave a spectrum indicative of racemization at the o- 
carbon of histidine. Major effects of racemization are 
also seen on the proline resonances, but there is no 
observable effect on those of the pyroglutamate res- 
idue. A doubling of the resonances of the o-carbons 
of histidine and proline is evident. Doubling can 
clearly be seen in the 6 carbon of proline, and in the 
fl and y carbon region of the spectrum four extra lines 
are visible. The two extra lines appearing in the 6 CH2 
region of proline are attributed to the cis and tram 
isomers of proline in the D-His-L-Pro-NH, residue; 
the separation between the lines is different from 
that of the cis and trans isomers of proline in the 
L-His-L-Pro-NH, sequence. In the imidazole ring, the 
D form of histidine is clearly manifest in the resonance 
of C-4; C-S shows a slight broadening but no effect 
is seen on C-2. An important observation here is that 
the nature of the doubling of the (II-CH resonances of 
proline by cis-trans isomerism depends heavily on the 
nature of the next residue. In Ac-Pro-NH* (in DZ 0) 
13 21 
N-CH 
TRF-R in D,O 
I 1 I / I t I 1 
100 160 140 I20 100 00 60 40 20 0 
PARTS PER MILLION FROM EXTERNAL TMS 
Fig.2. Carbon-13 NMR spectrum of sample of TRF containing both D and L isomers of histidine. Resonances assignable to species 
containing D-histidine are marked d. Experimental conditions same as fig.1 except 60 mg/ml, 10,000 transients, pulse width 40”, 
cycle time 0.4 set, 4096 data points. 
63 
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and Z-Pro-Leu-Gly-NH, [4,5] the resonance of the 
cis C-a is to low field of that of the tram C-CL In TRF 
(in Dz 0) the resonance of the cis C-Q is seen as a 
shoulder on the high field side of the tram C-cr reso- 
nance. When a D-histidine residue is present next to 
the proline (in TRF-R), the C-o resonance shifts up 
field. It is not possible at present to assert whether 
the predominant form of proline in this case is cis or 
trans. However if one looks at the C-8 resonance of 
proline in TRF-R in Dz 0 four lines are present. The 
two extra lines (which have been attributed to the 
presence of a D-histidine next to the proline) are al- 
most of equal intensity. This implies that the cis and 
tram isomers are almost equally favored in the se- 
quence -D-His-L-Pro-NH, in contrast to 14% cis 
isomer in the sequence -L-His-L-Pro-NH* . 
3.4. Solvent effects on histidine 
Changing solvent from DzO to DMSO-d6 or pyr- 
idine-d5 caused the disappearance of the resonances 
from the C-S and C-4 carbons of histidine. It is known 
that histidine forms strong complexes with paramag 
netic metal ions [ 14,151 . Proton magnetic resonance 
studies have shown that copper ions (Cu”‘) cause the 
two imidazole proton resonances to disappear [ 161. 
The effect in this case is not likely to be due to com- 
plexing with a paramagnetic metal ion impurity in the 
solvent because the C-2 resonance was unaffected, 
and the C-4 and C-S resonances reappeared when the 
sample was redissolved in D? 0. A possible explanation 
resides in the tautomeric equilibrium of the proton on 
N-l or N-3 of the imidazole ring of histidine. The res- 
onance of C-2 would be unaffected if the chemical 
shift of this carbon is unchanged by the presence of 
the proton on either nitrogen atom. However C-4 and 
C-S would have substantially different chemical shifts 
depending on whether the proton is on N-l or N-3. 
If the lifetime of the proton on each nitrogen is simi- 
lar to the inverse of the separation of the two chemi- 
cal shifts only a single broadened line will appear. 
Reynolds et al. [ 171 have found that the N-3 tauto- 
mer is predominant in histidine in basic solution; it 
would appear this is not true in DMSO-d6 or pyridine- 
ds. 
With increasing time in solution the C-2, C-4 and 
C-5 resonances of TRF, < Glu-His-OMe, and < Glu- 
His-NMe, in D? 0 broadened and finally disappeared. 
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Because all three resonances were affected it was 
thought that paramagnetic metal ions from solvents 
or syringe needles were responsible. To remove inter- 
fering ions H?S was bubbled through the solutions 
for 2 min. The solutions were left standing overnight 
and then centrifuged. After this procedure the 
imidazole ring carbon resonances reappeared in the 
correct positions, and no others in the spectra were 
affected. This confirms that the effect is due to met- 
al ions, as has been demonstrated in ‘H NMR studies 
P61. 
3.5. Spin-lattice relaxation time measurements 
Results of Tr measurements are given in table 3. 
In < Glu-His-OMe the relaxation time of the O-methyl 
carbon varies by a factor of three before and after 
treatment with H2 S. Before treatment it was shorter 
than that of an cr CH group, behaviour which is ex- 
pected for partial immobilization [8,18] or interac- 
tion with a paramagnetic ion. After Hz S treatment the 
relaxation time of the methyl group is twice as long 
as that of an CY CH carbon. This provides further con- 
firmation that before H?S treatment the His residue 
was interacting with paramagnetic metal ions. 
If dipole-dipole relaxation is the main relaxation 
mechanism, CH2 groups should relax twice as fast as 
CH groups [8,18] . This is generally observed for the 
CH and CH2 groups of histidine in all the compounds 
studied before and after H2S treatment, but not in the 
pyrrolidine and pyrrolidone rings of the prolyl and 
pyroglutamyl residues, respectively. There is evidence 
for conformational flexibility in the < Glu ring since 
the C-/3 and C-y Tr ‘.s are unequal and larger than ex- 
pected relative to that of C-o. The gradual decrease in 
the C-o Tr ‘s from < Glu to Pro suggests that the Pro 
end of the molecule has less mobility than the < Glu 
end. 
Carbonyl carbon relaxation times are difficult to 
measure at these concentrations due to their length. 
Preliminary results indicate that the shortest carbonyl 
relaxation time in TRF before H2S treatment is that 
of the histidyl residue. However, this may be mainly 
due to complexation with a paramagnetic impurity. 
No anomalies are noted in the carbonyl Tr values 
measured after H2S treatment. Thus far the Tr mea- 
surements give no suggestion of intramolecular hydro- 
gen bonds which have been suggested for TRF [16,20,21] . 
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Table 3 
Tr Measurements on TRF and model peptides in DzO, before and after treatment with hydrogen sulfide.+ 
Compound < Glu-His-OMe < Glu-His-NMez TRF 
< Glu 
His 
Pro 
QCH 
z; 
C=O (peptide) 
c=o 
CH3 
CYCH 
KHz 
c-2 
C-4 
c-5 
c=o 
CH3 
CH3 
oCH 
pCH2 
7CH2 
6CH, 
c=o 
C=O (acetyl) 
CH3 
Before After After 
.67 1.04 1.51 
.95 .95 1.04 
.88 1.02 .88 
.85 .73 
44 
.56 1.69 
+ Relaxation times are given in sec. 
The present data, and those for oxytocin [4-6,19, 
221, angiotensin [lo] , lysine and arginine vasopressin 
[5,19] arginine vasotocin [ 191 , melanocyte-stimula- 
ting hormone release-inhibiting factor, and luteinizing 
hormone-releasing factor [ 191 indicate that Fourier 
transform 13C NMR is a very sensitive and powerful 
means of studying the conformations of peptides 
without resort to isotopic enrichment. 
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